PAS
ALXO icon

Point72 Asia (Singapore)’s ALX Oncology ALXO Stock Holding History

Point72 Asia (Singapore)’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$25.4K Sell
13,907
-13,802
-50% -$12K ﹤0.01% 667
2025
Q2 		$11.5K Buy
+27,709
New +$14K ﹤0.01% 788
2024
Q4 		– Sell
-9,369
Closed -$17.1K – 856
2024
Q3 		$17.1K Buy
+9,369
New +$34.8K ﹤0.01% 833

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Point72 Asia (Singapore)'s ALXO Position: Q3 2025 in Review

Point72 Asia (Singapore) reduced its ALX Oncology (ALXO) stake by 50% in Q3 2025, selling an estimated $12K and leaving 13,907 shares worth $25.4K. The position accounts for ﹤0.01% of the portfolio, ranked #667.

Point72 Asia (Singapore) first reported a position in ALXO in Q3 2024 and has held it in 3 quarters since. 61 funds tracked by Wall St. Rank hold ALXO as of Q3 2025.

  • Point72 Asia (Singapore) held 13,907 shares of ALX Oncology worth $25.4K as of Q3 2025.
  • Point72 Asia (Singapore) sold 13,802 ALX Oncology shares in Q3 2025, an estimated $12K.
  • ALX Oncology made up ﹤0.01% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #667 holding.
  • Point72 Asia (Singapore) first reported a position in ALX Oncology in Q3 2024 and has held it in 3 quarters since.
  • 61 funds tracked by Wall St. Rank held ALX Oncology as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.